Discover open access scientific publications

Search, annotate, share and cite publications

Publications by V. Diehl

Ebeacopp With or Without Rituximab in Interim-Pet-Positive Advanced-Stage Hodgkin Lymphoma: Updated Results of the International, Randomized Phase 3 GHSG Hd18 Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Relation Between Epstein-Barr Viral and Cell Membrane Immunofluorescence in Burkitt Tumor Cells: Ii. Comparison of Cells and Sera From Patients With Burkitt's Lymphoma and Infectious Mononucleosis

Journal of Experimental Medicine
MedicineAllergyImmunology
1968English

Related publications

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology
Hematology
2018English

The 23-Gene Gene Expression-Based Assay Does Not Predict Interim Pet Scan Results After Abvd in Advanced Stage Classical Hodgkin Lymphoma in the Us Intergroup S0816 Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

PET-guided Treatment in Advanced-Stage Hodgkin Lymphoma: Yes but Which One?

Oncotarget
Oncology
2019English

T(11;18)(q21;q21)-Positive Advanced-Stage MALT Lymphoma Associated With Monoclonal Gammopathy : Resistance to Rituximab or Rituximab-Containing Chemotherapy

Journal of clinical and experimental hematopathology : JCEH
Medicine
2008English

Patient Outcomes With and Without Radiotherapy for Early Stage Hodgkin Lymphoma in the Post-Pet Era

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma

British Journal of Haematology
Hematology
2017English

UPDATED SAFETY AND EFFICACY RESULTS OF «HLMoscow 1-3» STUDY FOR THE 147 UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Quantitative Assessment of Interim PET in Hodgkin Lymphoma: An Evaluation of the qPET Method in Adult Patients in the RAPID Trial

PLoS ONE
Multidisciplinary
2020English

Ncri Petrea Trial: A Phase 3 Evaluation of Pet-Guided, Response-Adapted Therapy in Patients With Previously Untreated, Advanced-Stage, High-Tumour-Burden Follicular Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy